Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2019

Feb 1, 2019

30893_dirs_2019-02-01_cd763919-6bbd-496e-8dcc-1d10b55b8b0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2019-01-31

Reporting Person: Wallace James H (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-01-31 Common Stock M 12000.00 $11.195 Acquired 29400.00 Direct
2019-01-31 Common Stock M 12000.00 $15.855 Acquired 41400.00 Direct
2019-01-31 Common Stock S 24000.00 $21.3961 Disposed 17400.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-01-31 Non-employee Director Stock Option (Right to buy) $15.855 M 12000.00 Disposed 2021-05-12 Common Stock (12000.00) Direct
2019-01-31 Non-employee Director Stock Option (Right to buy) $11.195 M 12000.00 Disposed 2022-05-17 Common Stock (12000.00) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $21.375 to $21.435. The price reported above reflects the weighted average price.